FDA.reportPublic FDA data

PMA P040024S120

Device
Restylane, Perlane, Restylane-L, Restylane Lyft with Lidocane and Restylane Silk Injectable Gels
Applicant
Q-Med AB
PMA number
P040024
Supplement
S120
Product code
LMH
Decision date
2020-10-14
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Changes to the distribution systems for water for injection (WFI) and compressed air distribution systems at the Uppsala, Sweden manufacturing facility for Restylane, Perlane, Restylane –L, Restylane Lyft with Lidocaine and Restylane Silk.

Current openFDA PMA Record#

Device
Restylane, Perlane, Restylane-L, Restylane Lyft with Lidocane and Restylane Silk Injectable Gels
Applicant
Q-Med AB
PMA number
P040024
Supplement
S120
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2020-10-14
Decision code
OK30
Date received
2020-09-14
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Changes to the distribution systems for water for injection (WFI) and compressed air distribution systems at the Uppsala, Sweden manufacturing facility for Restylane, Perlane, Restylane –L, Restylane Lyft with Lidocaine and Restylane Silk.